Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christina Claus

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Mabs|February 2, 2023
The emerging landscape of novel 4-1BB (CD137) agonistic drugs for cancer immunotherapyChristina Claus, Claudia Ferrara-Koller, Christian Klein
European Journal of Immunology|May 29, 2008
CD4+ T cell help improves CD8+ T cell memory by retained CD27 expressionMatthias S Matter, Christina Claus, Adrian F Ochsenbein
European Journal of Immunology|September 14, 2010
Chronic myelogenous leukemia maintains specific CD8(+) T cells through IL-7 signalingSabine Mumprecht, Christian Schürch, Sandro Scherrer, et al.
Blood|March 3, 2009
Defective homing and impaired induction of cytotoxic T cells by BCR/ABL-expressing dendritic cellsSabine Mumprecht, Christina Claus, Christian Schürch, et al.
Cancer Research|May 26, 2012
CD27 signaling increases the frequency of regulatory T cells and promotes tumor growthChristina Claus, Carsten Riether, Christian Schürch, et al.
Frontiers in Pharmacology|October 24, 2024
Combining mathematical modeling, <i>in vitro</i> data and clinical target expression to support bispecific antibody binding affinity selection: a case example with FAP-4-1BBLJavier Sanchez, Christina Claus, Christine McIntyre, et al.
Plos One|October 4, 2011
Destruction of lymphoid organ architecture and hepatitis caused by CD4+ T cellsMatthias S Matter, Tamara Hilmenyuk, Christina Claus, et al.
Blood|May 13, 2017
CD70 reverse signaling enhances NK cell function and immunosurveillance in CD27-expressing B-cell malignanciesMohamad F Al Sayed, Carla A Ruckstuhl, Tamara Hilmenyuk, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 15, 2023
A model-based approach leveraging in vitro data to support dose selection from the outset: A framework for bispecific antibodies in immuno-oncologyJavier Sánchez, Christina Claus, Rosmarie Albrecht, et al.
The Plant Cell|November 15, 2005
NAB1 is an RNA binding protein involved in the light-regulated differential expression of the light-harvesting antenna of Chlamydomonas reinhardtiiJan H Mussgnug, Lutz Wobbe, Ingolf Elles, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Mabs|February 2, 2023
The emerging landscape of novel 4-1BB (CD137) agonistic drugs for cancer immunotherapyChristina Claus, Claudia Ferrara-Koller, Christian Klein
European Journal of Immunology|May 29, 2008
CD4+ T cell help improves CD8+ T cell memory by retained CD27 expressionMatthias S Matter, Christina Claus, Adrian F Ochsenbein
European Journal of Immunology|September 14, 2010
Chronic myelogenous leukemia maintains specific CD8(+) T cells through IL-7 signalingSabine Mumprecht, Christian Schürch, Sandro Scherrer, et al.
Blood|March 3, 2009
Defective homing and impaired induction of cytotoxic T cells by BCR/ABL-expressing dendritic cellsSabine Mumprecht, Christina Claus, Christian Schürch, et al.
Cancer Research|May 26, 2012
CD27 signaling increases the frequency of regulatory T cells and promotes tumor growthChristina Claus, Carsten Riether, Christian Schürch, et al.
Frontiers in Pharmacology|October 24, 2024
Combining mathematical modeling, <i>in vitro</i> data and clinical target expression to support bispecific antibody binding affinity selection: a case example with FAP-4-1BBLJavier Sanchez, Christina Claus, Christine McIntyre, et al.
Plos One|October 4, 2011
Destruction of lymphoid organ architecture and hepatitis caused by CD4+ T cellsMatthias S Matter, Tamara Hilmenyuk, Christina Claus, et al.
Blood|May 13, 2017
CD70 reverse signaling enhances NK cell function and immunosurveillance in CD27-expressing B-cell malignanciesMohamad F Al Sayed, Carla A Ruckstuhl, Tamara Hilmenyuk, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 15, 2023
A model-based approach leveraging in vitro data to support dose selection from the outset: A framework for bispecific antibodies in immuno-oncologyJavier Sánchez, Christina Claus, Rosmarie Albrecht, et al.
The Plant Cell|November 15, 2005
NAB1 is an RNA binding protein involved in the light-regulated differential expression of the light-harvesting antenna of Chlamydomonas reinhardtiiJan H Mussgnug, Lutz Wobbe, Ingolf Elles, et al.
Pageof 2